Navigation Links
SFU HIV/AIDS vaccine research gets financial boost
Date:4/3/2012

Jamie Scott, a Simon Fraser University professor and Canada Research Chair in molecular immunity, and three international collaborators are getting a hefty financial boost in their efforts to develop an effective HIV/AIDS vaccine.

The United States National Institutes of Health (NIH) has awarded the four researchers $2.7 million to help them improve the effectiveness of a DNA-based vaccine that Marinieve Montero first conceived of eight years ago. Montero was a student of Scott's whose work was also funded by the NIH, the U.S.'s largest government-funded medical research agency.

Scott's current collaborators are at the University of the Basque Country, the University of Massachusetts School of Medicine and the University of California, San Francisco.

The researchers will use their new funding to strengthen a vaccine they've made from a DNA fragment taken from the HIV genome. The fragment encodes something that is highly prized in HIV/AIDS vaccine research. Called the MPER, it's a region of the HIV envelope that retains mutations at a very low level compared to the rest of the virus's genome, which continually mutates.

The MPER doesn't retain mutations because they would hamper the virus's ability to infect cells and duplicate itself.

"The real challenge to creating antibodies that fight a constantly mutating virus like HIV," explains Scott, "is finding a region on the virus's surface protein that rarely mutates. That provides an exposed site that does not change from virus to virus and that antibodies can attack. The MPER is such a site."

While other researchers have made vaccines that expose a subject's immune system to a synthetic version of the MPER, the vaccines have not triggered the production of antibodies that recognize and attack HIV.

Scott and her partners believe this is because synthetic MPER vaccines to-date have not replicated the viral MPER accurately, but say their new vaccines
'/>"/>

Contact: Carol Thorbes
cthorbes@sfu.ca
778-782-3035
Simon Fraser University
Source:Eurekalert

Page: 1 2

Related biology news :

1. CWRU study finds the love of a dog or cat helps women cope with HIV/AIDS
2. HIV/AIDS vaccine developed at Western proceeding to human clinical trials
3. Tropical disease experts report missed opportunity to transform global HIV/AIDS fight
4. Scripps Florida scientist awarded $3.4 million for HIV/AIDS research
5. A Trojan horse in the fight against HIV/AIDS
6. Plenary speakers address challenges in the delivery of sustained antiretroviral therapy in developing countries, call for social scientists to take their place at the HIV/AIDS policy-making table, and stress the need for a long-term response to AIDS
7. 2020 vision of vaccines for malaria, TB and HIV/AIDS
8. Advances in HIV/AIDS prevention and treatment
9. Using hair to manage HIV/AIDS and predict treatment success
10. Cutting-edge amfAR grants fight HIV/AIDS in the lab and on the phone
11. NTDs burden in Latin America and the Caribbean may exceed that of HIV/AIDS, TB and malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... -- Curemark LLC, a privately held drug research and ... III double blind, randomized, placebo-controlled clinical trial to examine ... children ages 3-8 with Autism. Previously, Curemark announced the ... clinical trial for CM-AT in children ages 3-8 with ... chymotrypsin. This new trial will help determine whether all ...
(Date:5/5/2015)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or the ... commerce market, reminds investors and media that  Mr. David ... CARTES SECURE CONNEXIONS AMERICA 2015, held in Washington ... three-day conference is organized into a series of nine session ... Global Fraud: Where is the Trust in Cyberspace? and ...
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial Hospital ... to implant a new miniaturized, wireless monitoring sensor to ... the first and only FDA-approved heart failure monitoring device ... when used by physicians to manage heart failure. ... is implanted in the pulmonary artery (PA) during a ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... have found that the main source of food for many ... to adapt in order to survive climate change. Billions ... just a few millimetres in size, live in the waters ... It showed they responded to global warming after the ...
... Enhanced Recognition Capabilities for Use in ... and Computer Vision Applications, VILNIUS, ... ), a provider of high-precision biometric,and ... availability of,SentiSight 2.0 SDK universal object ...
... First Such Board on the Market, Stantum,s SMK ... Their Own Resistive Multi-Touch Applications, SAN DIEGO, ... pioneer developer of multi-touch sensing,technology, today introduced a ... PMatrix(TM) resistive multi-touch technology, which lets,users simultaneously move ...
Cached Biology News:Researchers find animal with ability to survive climate change 2Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology 2Neurotechnology Releases SentiSight 2.0 SDK Universal Object Recognition Technology 3Stantum Offering Demo, Evaluation & Development Board Based on Its Patented Resistive Multi-Touch Technology 2
(Date:5/28/2015)... (PRWEB) May 28, 2015 DryLet, ... use in applications such as animal waste reduction, ... oil reduction in wastewater treatment plants and restaurant ... the World Pork Expo, June 3-5 in Des ... year in a Wall Street Journal article because ...
(Date:5/28/2015)... N.J. , May 28, 2015  PDS ... a cancer immunotherapy treatment targeting HPV-16, has generated ... Currently, pre-cervical cancer is treated by ... a simple and effective non-surgical alternative. Results show ... mechanisms (T-cells) to recognize, target, and kill precancerous ...
(Date:5/28/2015)... 2015 Biscayne Pharmaceuticals, Inc ., today ... growth hormone-releasing hormone (GHRH) technology will be discussed in a ... Meeting. The data show that the family of receptors ... is present on many primary breast cancer cells regardless ... antagonists could have broad anti-cancer potential in breast cancer. ...
(Date:5/28/2015)... and London (PRWEB) May 28, 2015 ... of Computer Aided Engineering software, announced today it ... Inc. (PSRI). CD-adapco will provide state-of-the-art engineering simulation ... will share their expertise and experiences in analyzing ... refining industry members and advance the understanding of ...
Breaking Biology Technology:DryLet to Showcase Patented ManureMagicâ„¢ at the 2015 World Pork Expo, June 3-5 in Des Moines, Iowa 2PDS Biotechnology reports positive Phase I clinical trial results in proprietary HPV-Cancer Immunotherapy 2Data Presented At 2015 ASCO Annual Meeting Shows Biscayne Pharmaceuticals' GHRH Antagonist Target Is Expressed Across All Breast Cancer Subtypes 2Data Presented At 2015 ASCO Annual Meeting Shows Biscayne Pharmaceuticals' GHRH Antagonist Target Is Expressed Across All Breast Cancer Subtypes 3CD-adapco and PSRI Chartering New Course in Particle Flow Simulations 2
... Ill., July 1 Healthation, a healthcare,technology ... large Canadian Third,Party Administrator (TPA) to a ... use,the integrated real-time, rules-based AcceleHealth(R) benefits and ... deliver interactive,self-service capabilities across its medical, dental, ...
... Mich., July 1 Neogen Corporation,(Nasdaq: NEOG ... product line used in,animal health and hygiene applications ... includes 14 different product formulations,along with manufacturing process ... terms were not disclosed., The addition of ...
... BioMarin,Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that ... present a,company update at the Collins Stewart Growth Conference ... 9:30 a.m. ET., Interested parties may access a ... of the BioMarin website, http://www.BMRN.com . A,replay of ...
Cached Biology Technology:Healthation Chosen by Large Canadian Third Party Administrator to Support All Employee Benefits and Claims Administration 2Neogen Acquires Product Line From DuPont Animal Health Solutions 2BioMarin to Present at the Collins Stewart Growth Conference 2
Leucine-rich repeat-containing G-protein coupled receptor 4...
WD-repeat protein 4...
Rabbit polyclonal to MDM2 (phospho S185) ( Abpromise for all tested applications). entrezGeneID: 4193 SwissProtID: Q00987...
... Cultured human omental preadipocytes ... but otherwise healthy donors. ... of diabetic cells. Please ... Support media also available. ...
Biology Products: